Cited by 1,163Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Open access

Stampfer, Meir J., Sacks, Frank M., Salvini, Simonetta, Willett, Walter C., Hennekens, Charles H.·1991·New England Journal of Medicine

DOI 10.1056/nejm199108083250601

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The independent contributions of subfractions of high-density lipoprotein (HDL) cholesterol (HDL2 and HDL3) and apolipoproteins in predicting the risk of myocardial infarction are unclear. Prospective data are sparse, but HDL2 is widely believed to be a more important predictor than HDL3. METHODS: Blood samples were collected at base line from 14,916 men (ages, 40 to 84 years) who were participants in the Physicians' Health Study. After five years of follow-up, plasma samples from 246 men with new myocardial infarction (case subjects) were analyzed together with specimens from 246 men matched to them for age and smoking status who had not had a myocardial infarction. RESULTS: The levels of total cholesterol and apolipoprotein B-100 were significantly associated with an increased risk of myocardial infarction (data on levels of low-density lipoprotein cholesterol were unavailable). Both HDL cholesterol and HDL2 levels were associated with a substantially decreased risk of myocardial infarction, but the HDL3 level was the strongest predictor; the relative risk was 0.3 (95 percent confidence interval, 0.2 to 0.6) for those in the fifth of the group with the highest HDL3 levels, as compared with the fifth with the lowest levels. The benefit of a higher HDL cholesterol level was most pronounced among those with lower total cholesterol levels. Levels of apolipoprotein A-I and apolipoprotein A-II were also associated with decreased risk. However, the levels of HDL subfractions and apolipoproteins did not add significantly to the value of a multivariate model that included the ratio of total to HDL cholesterol in predicting myocardial infarction, whereas that ratio remained a significant independent predictor of risk. After adjustment for other risk factors, a change of one unit in the ratio of total to HDL cholesterol was associated with a 53 percent change in risk (95 percent confidence interval, 26 percent to 85 percent). CONCLUSIONS: This study underscores the importance of HDL cholesterol in predicting the risk of myocardial infarction and demonstrates protective effects of both the HDL3 and HDL2 subfractions of HDL cholesterol. We found little or no predictive value for the levels of apolipoproteins A-I, A-II, and B or HDL subfractions after conventional risk factors and the ratio of total to HDL cholesterol were considered.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108083250601

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

From the New York Times Magazine
Minsky, & Hyman, P. (1979) · Cited by 6,899
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
THE TROMSØHEART-STUDY
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,206
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Ischemic Heart Disease, Atherosclerosis, and Longevity
Gofman, J. W., Young, W., & Tandy, R. K. (1966) · Circulation · doi:10.1161/01.cir.34.4.679 · Cited by 587
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
Goodman, D. S., Hulley, S. B., Clark, L. T., Davis, C. E., Fuster, V., LaRosa, J. C., Oberman, A., Schaefer, E. J., Steinberg, D., Brown, W. V., et al. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.1.36 · Cited by 529
ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
Avogaro, P., Bon, G. B., Avogaro, P., Cazzolato, G., & Quinci, G. B. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91375-8 · Cited by 523

Show all 56 references

Research works printed but not linked: 10

Enger, 1979, Artery, 5, 170
Bennett, 1988, New York Times Magazine, 55
Jones PH, Gotto AM Jr. Assessment of lipid abnormalities. In: Hurst JW, Schlant RC, Rachley CE, Sonnenblick EH, Wenger NK, eds. The heart: arteries and veins. 7th ed. New York: McGraw-Hill, 1990:378–84.
10.1001/archinte.150.8.1645 · DOI
Musliner, 1988, Clin Chem, 34, B78
Hennekens, 1987, Circulation, 76, IV-501
Kempen, 1987, J Lab Clin Med, 109, 19
Avogaro P, Cazzolato G, Bittolo Bon G, Rorai E, Pontoglio E. Lipoprotein derangements in human atherosclerosis. In: Noseda G, Fragiacomo C, Fumagalli R, Paoletti R, eds. Lipoproteins and coronary atherosclerosis. Amsterdam: Elsevier, 1982:123–42.
Kladetzky, 1980, Artery, 7, 191
Desager JP, Rousseau M, Riesen WF, Harvengt C. Limitations of the predictive value for coronary vascular disease of plasma lipids and apoproteins AI, AII, B levels as measured before coronarography in 317 patients. In: de Gennes JL, Polonovski J, Paoletti R, eds. Latent dyslipoproteinemias and atherosclerosis. New York: Raven Press, 1984:165–74.

Sorted by citations

Items 501–600 of 999

DXA‐derived Abdominal Fat Mass, Waist Circumference, and Blood Lipids in Postmenopausal Women
Vatanparast, H., Chilibeck, P. D., Cornish, S. M., Little, J. P., Paus-Jenssen, L., Case, A. M., & Biem, H. J. (2009) · Obesity · doi:10.1038/oby.2009.80 · Cited by 33
Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity
Harangi, M., Mirdamadi, H. Z., Seres, I., Sztanek, F., Molnár, M., Kassai, A., Derdák, Z., Illyés, L., & Paragh, G. (2009) · Translational research · doi:10.1016/j.trsl.2009.01.007 · Cited by 34
Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers
Schäfer, C., Parlesak, A., Eckoldt, J., Bode, C., Bode, J. C., März, W., & Winkler, K. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600513-jlr200 · Cited by 33
Particle size measurement of lipoprotein fractions using diffusion-ordered NMR spectroscopy
Mallol, R., Rodriguez, M. A., Heras, M., Vinaixa, M., Plana, N., Masana, L., Morris, G. A., & Correig, X. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5705-9 · Cited by 32
A Very High Prevalence of Low HDL Cholesterol in Spanish Patients With Acute Coronary Syndromes
Pintó, X., Millán, J., Muñoz, A., Corbella, E., Hernández‐Mijares, A., Zuñiga, M., Mangas, A., & Pedro‐Botet, J. (2010) · Clinical Cardiology · doi:10.1002/clc.20774 · Cited by 31
The relationship between alcohol consumption and earnings.
Heien, D. (1996) · Journal of Studies on Alcohol · doi:10.15288/jsa.1996.57.536 · Cited by 32
Plasma apolipoproteins A-I and B in survivors of myocardial infarction and in a control group
Graziani, M. S., Zanolla, L., Righetti, G., Marchetti, C., Mocarelli, P., & Marcovina, S. M. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.1.134 · Cited by 32
Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels
Papademetriou, V., Narayan, P., Bloomfield, H. E., Collins, D. E., & Robins, S. J. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70023-7 · Cited by 32
Hypertriglyceridemia: A Review of Clinical Relevance and Treatment Options: Focus on Cerivastatin
Breuer, H.-W. M. (2001) · Current Medical Research and Opinion · doi:10.1185/03007990152005379 · Cited by 31
Effect of vitamin C supplementation on lipoprotein cholesterol, apolipoprotein, and triglyceride concentrations
Jacques, P. F., Sulsky, S. I., Perrone, G., Jenner, J. L., & Schaefer, E. J. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00041-q · Cited by 31
Association of heterozygous familial hypercholesterolemia with smaller HDL particle size
Hogue, J., Lamarche, B., Gaudet, D., Tremblay, A. J., Després, J., Bergeron, J., Gagné, C., & Couture, P. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.023 · Cited by 31
Relation of a Common Mutation in Methylenetetrahydrofolate Reductase to Plasma Homocysteine and Early Onset Coronary Artery Disease
Dunn, J., Title, L. M., Bata, I. R., Johnstone, D. E., Kirkland, S., O’Neill, B. J., Zayed, E., MacDonald, M. C., Dempsey, G. I., & Nassar, B. A. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(97)00165-3 · Cited by 31
A randomised comparison of the effects of oral versus transdermal 17β‐oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels
Spencer, C., Crook, D., Ross, D., Cooper, A. J., Whitehead, M. I., & Stevenson, J. C. (1999) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1999.tb08435.x · Cited by 31
Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity
Kahri, J., Vuorinen-Markkola, H., Tilly-Kiesi, M., Lahdenperä, S., & Taskinen, M. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90086-a · Cited by 31
Effects of magnitude of visceral adipose tissue reduction: Impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term weight-loss therapy
Campos, R. M. D. S., Masquio, D. C. L., Corgosinho, F. C., Caranti, D. A., de Piano, A., Tock, L., Oyama, L. M., & Dâmaso, A. R. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118825343 · Cited by 30
Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease.
Schlitt, A., Blankenberg, S., Bickel, C., Meyer, J., Hafner, G., Jiang, X.-C., & Rupprecht, H. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.05.056 · Cited by 33
Relation of high-density lipoprotein subfractions and apolipoprotein E isoforms to coronary disease
Wilson, P. W. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.165 · Cited by 29
Psychological factors in the relationship between alcohol and cardiovascular morbidity
Roberts, R. E., Brunner, E. J., & Marmot, M. G. (1995) · Social Science & Medicine · doi:10.1016/0277-9536(95)00056-d · Cited by 30
Validity of a short diet-quality index to predict changes in anthropometric and cardiovascular risk factors: a simulation study
Funtikova, A. N., Baena-Díez, J. M., Koebnick, C., Gómez, S. F., Covas, M.-I., Goday, A., & Schröder, H. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.131 · Cited by 29
Apolipoprotein A-I and risk for cardiovascular diseases
Arnold, N., & Köenig, W. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0033-9 · Cited by 29
Implications of torcetrapib failure for the future of HDL therapy: is HDL-cholesterol the right target?
von Eckardstein, A. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.6 · Cited by 30
Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis—results from the IDEA study
Bissell, L.-A., Hensor, E. M. A., Kozera, Ł., Mackie, S. L., Burska, A. N., Nam, J. L., Keen, H. I., Villeneuve, É., Donica, H., Buch, M. H., et al. (2016) · Rheumatology · doi:10.1093/rheumatology/kew306 · Cited by 31
Glaucoma risk factor assessment and prevention: Lessons from coronary heart disease
Girkin, C. A., Kannel, W. B., Friedman, D. S., & Weinreb, R. N. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.04.060 · Cited by 29
A Prospective, Randomized Trial of Phenytoin in Nonepileptic Subjects With Reduced HDL Cholesterol
Miller, M. J., Burgan, R. G., Osterlund, L., Segrest, J. P., & Garber, D. W. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.12.2151 · Cited by 29
Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease
Brousseau, M. E., Goldkamp, A. L., Collins, D. E., Demissie, S., Connolly, A. C., Cupples, L. A., Ordovás, J. M., Bloomfield, H. E., Robins, S. J., & Schaefer, E. J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400152-jlr200 · Cited by 29
Dose-Response Relationships of Serum Lipid Measurements With the Extent of Coronary Stenosis
Bolíbar, I., Thompson, S. G., von Eckardstein, A., Sandkamp, M., & Assmann, G. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1035 · Cited by 29
HDL Heterogeneity and Atherosclerosis
Tailleux, A., Fruchart, J., & Parkes, J. G. (1996) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369609083060 · Cited by 29
Effects of dietary intakes on plasma lipids, lipoproteins, and apolipoproteins in free-living elderly men and women
Lamon‐Fava, S., Jenner, J., Jacques, P. F., & Schaefer, E. J. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.1.32 · Cited by 29
Hyperlipidemia in long‐term survivors of pediatric renal transplantation
Sharma, A. K., Myers, T. A., Hunninghake, D. B., Matas, A. J., & Kashtan, C. E. (1994) · Clinical Transplantation · doi:10.1111/j.1399-0012.1994.tb00249.x · Cited by 29
Inflammation and dyslipidaemia: a possible interplay between established risk factors in North Indian males with coronary artery disease.
Goswami, B., Rajappa, M., Singh, B. M., Ray, P., Kumar, S., & Mallika, V. (2010) · Europe PMC (PubMed Central) · Cited by 28
Associação entre doença periodontal e síndrome coronariana aguda
Rech, R. L., Nurkin, N., da Cruz, I. B. M., Sostizzo, F., Baião, C. G., Perrone, J. A., Wainstein, R. V., Pretto, D., Manenti, E. R. F., & Bodanese, L. C. (2007) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2007000200009 · Cited by 28
Risk Assessment for Coronary Heart Disease in a Veteran Population with Spinal Cord Injury
Bauman, W. A., & Spungen, A. M. (2007) · Topics in Spinal Cord Injury Rehabilitation · doi:10.1310/sci1204-35 · Cited by 28
Eriosema laurentii De Wild (Leguminosae) methanol extract has estrogenic properties and prevents menopausal symptoms in ovariectomized Wistar rats
Ateba, S. B., Njamen, D., Medjakovic, S., Hobiger, S., Mbanya, J. C., Jungbauer, A., & Krenn, L. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.08.050 · Cited by 28
Population Genetic Analysis of the Genes APOE, APOB (3′VNTR) and ACE in Some Black and Amerindian Communities from Colombia
Jaramillo‐Correa, J. P., Keyeux, G., Ruiz‐García, M., Rodas, C., & Bernal, J. E. (2001) · Human Heredity · doi:10.1159/000053351 · Cited by 28
The Correlation between Lipids Ratio and Degree of Coronary Artery Stenosis
Yang, D., Liu, X., & Xiang, M. (2011) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/11593480-000000000-00000 · Cited by 28
Risk Factors for Atherosclerotic Vascular Disease
von Eckardstein, A. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-27661-0_2 · Cited by 30
Changes in Cardiovascular Functions, Lipid Profile, and Body Composition at High Altitude in Two Different Ethnic Groups
Vats, P., Ray, K., Majumadar, D., Amitabh, Joseph, D. A., Bayen, S., Akunov, A., Sarbaev, A., & Singh, S. B. (2013) · High Altitude Medicine & Biology · doi:10.1089/ham.2012.1071 · Cited by 28
Evolution of Lipid Profile, Liver Function, and Pattern of Plasma Fatty Acids According to the Type of Lipid Emulsion Administered in Parenteral Nutrition in the Early Postoperative Period After Digestive Surgery
Puiggròs, C., Sánchez, J. L., Chacón, P. M., Sabín, P., Roselló, J., Bou, R., & Planas, M. (2009) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607109333001 · Cited by 29
Dietary modification of high density lipoprotein phospholipid and influence on cellular cholesterol efflux
Gillotte, K. L., Lund‐Katz, S., de la Llera-Moya, M., Parks, J. S., Rudel, L. L., Rothblat, G. H., & Phillips, M. C. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32505-0 · Cited by 28
Epidemiologic evidence for the cardioprotective effects associated with consumption of alcoholic beverages
Grønbæk, M. (2003) · Pathophysiology · doi:10.1016/j.pathophys.2003.10.004 · Cited by 28
Lipids, Apolipoproteins and Lipoproteins
Rader, D. J., & Brewer, H. B. (1994) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1130-0_6 · Cited by 27
Levels of Soluble Cell Adhesion Molecules in Patients With Angiographically Defined Coronary Atherosclerosis
Saku, K., Zhang, B., Ohta, T., Shirai, K., Tsuchiya, Y., & Arakawa, K. (1999) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.63.19 · Cited by 28
ApoA-II kinetics in humans using endogenous labeling with stable isotopes: slower turnover of apoA-II compared with the exogenous radiotracer method
Ikewaki, K., Zech, L. A., Brewer, H. B., & Rader, D. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37626-4 · Cited by 28
Serum Apolipoprotein A-1 Quantification by LC–MS with A Silac Internal Standard Reveals Reduced Levels in Smokers
Wang, Q., Zhang, S., Guo, L., Busch, C. M., Jian, W., Weng, N., Snyder, N. W., Rangiah, K., Mesaros, C., & Blair, I. A. (2015) · Bioanalysis · doi:10.4155/bio.15.195 · Cited by 27
Association between remnant cholesterol and arterial stiffness: A secondary analysis based on a cross‐sectional study
Wang, Z., Li, M., Xie, J., Gong, J., & Liu, N. (2021) · Journal of Clinical Hypertension · doi:10.1111/jch.14384 · Cited by 26
The effect of consumption of low-glycemic-index and low-glycemic-load desserts on anthropometric parameters and inflammatory markers in patients with type 2 diabetes mellitus
Argiana, V., Kanellos, P. T., Makrilakis, K., Eleftheriadou, I., Tsitsinakis, G., Kokkinos, A. D., Perrea, D. N., & Tentolouris, N. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0795-8 · Cited by 27
Evaluation of non-HDL-c and total cholesterol: HDL-c Ratio as Cumulative Marker of Cardiovascular Risk in Diabetes Mellitus
Aryal, M. S., Poudel, A., Satyal, B., Gyawali, P., Pokheral, B. R., Raut, B., Adhikari, R., & Koju, R. (2012) · Kathmandu University Medical Journal · doi:10.3126/kumj.v8i4.6239 · Cited by 26
Public discourse on the benefits of moderation: implications for alcohol policy development
Casswell, S. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02052.x · Cited by 27
Predictive Value of Lipid Profile for Salutary Coronary Angiographic Changes in Patients on a Low-Fat Diet and Physical Exercise Program
Niebauer, J., Hambrecht, R., Velich, T., Marburger, C., Hauer, K. A., Kreuzer, J., Zimmermann, R., von Hodenberg, E., Schlierf, G., Schuler, G. C., et al. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)90390-2 · Cited by 27
Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants
Kim, Y. S., Kim, M. S., Kim, S. I., Lim, S. K., Lee, H. Y., Han, D. S., & Park, K. (1997) · Transplant International · doi:10.1007/s001470050041 · Cited by 27
Changes in Women’s Plasma Lipid and Lipoprotein Concentrations Due to Moderate Consumption of Alcohol Are Affected by Dietary Fat Level
Rumpler, W. V., Clevidence, B. A., Muesing, R. A., & Rhodes, D. G. (1999) · Journal of Nutrition · doi:10.1093/jn/129.9.1713 · Cited by 27
Distribution of subclasses of HDL containing apoA-I without apoA-II (LpA-I) in normolipidemic men and women.
Duverger, N., Rader, D. J., & Brewer, H. B. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1594 · Cited by 27
Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension
Carruthers, G., Dessain, P., Fodor, G. J., Newman, C., Palmer, W. H., & Sim, D. A. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90514-d · Cited by 27
HDL and cardiovascular risk: is cholesterol in particle subclasses relevant?
Gebhard, C., Rhainds, D., & Tardif, J. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu306 · Cited by 27
Skeptical Look at the Clinical Implication of Metabolic Syndrome in Childhood Obesity
Wasniewska, M. G., Pepe, G., Aversa, T., Bellone, S., SANCTIS, L. D., Bonito, P. D., Faienza, M. F., Improda, N., Licenziati, M. R., Maffeis, C., et al. (2023) · Children · doi:10.3390/children10040735 · Cited by 25
Ácidos graxos trans: implicações nutricionais e fontes na dieta
Martin, C. A., Matshushita, M., & de Souza, N. E. (2004) · Revista de Nutrição · doi:10.1590/s1415-52732004000300009 · Cited by 25
Comparison of the quality of diabetes care in primary care diabetic clinics and general practice clinics
Khaja, K. A. J. A., Sequeira, R. P., & Damanhori, A. H. H. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.029 · Cited by 25
Water dispersible plant sterol formulation shows improved effect on lipid profile compared to plant sterol esters
Shaghaghi, M. A., Harding, S., & Jones, P. J. H. (2013) · Journal of Functional Foods · doi:10.1016/j.jff.2013.10.017 · Cited by 26
Cholesterol ester transfer protein, apolipoprotein E and lipoprotein lipase genotypes in patients with coronary artery disease in the Turkish population
İşbir, T., Yılmaz, H., Ağaçhan, B., & Karaali, Z. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00137.x · Cited by 26
Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease
Bahri, R., Esteban, E. M., Moral, P., Hassine, M., Hamda, K. B., & Chaabani, H. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-46 · Cited by 25
Association of GSTT1 and GSTM1 gene polymorphisms with coronary artery disease in North Indian Punjabi population: a case-control study
Bhat, M. A., & Gandhi, G. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133836 · Cited by 25
Apolipoprotein e4 allele is predictor of coronary artery disease death in elderly patients with type 2 diabetes mellitus
Xiang, G., You-ying, L., Zhi-song, C., Yu-sheng, H., & Xiang-jiu, Y. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.02.015 · Cited by 25
Predictors of 14-year changes in the total cholesterol to high-density lipoprotein cholesterol ratio in men
Scranton, R. E., Sesso, H. D., Stampfer, M. J., Levenson, J. W., Buring, J. E., & Gaziano, J. M. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.11.018 · Cited by 25
Self-citation
Ethnicity effect on the serum lipid profile in persons with spinal cord injury
Bauman, W. A., Adkins, R. H., Spungen, A. M., Maloney, P., Gambino, R., & Waters, R. L. (1998) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(98)90296-9 · Cited by 25
Effects of bezafibrate and pravastatin on remnant-like lipoprotein particles and lipoprotein subclasses in type 2 diabetes
Kazama, H., Usui, S., Okazaki, M., Hosoi, T., Ito, H., & Orimo, H. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00243-7 · Cited by 25
Metabolic risk factors for coronary heart disease: current and future prospects
Wilson, P. W. F. (1999) · Current Opinion in Cardiology · doi:10.1097/00001573-199903000-00016 · Cited by 25
Coronary heart disease risk factors in older persons
Corti, M. C., Guralnik, J. M., & Bilato, C. (1996) · Aging Clinical and Experimental Research · doi:10.1007/bf03339560 · Cited by 25
Long-Term Effects of Continuous Combined HRT on Bone Turnover and Lipid Metabolism in Postmenopausal Women
Hart, D. M., FARISH, E., Fletcher, C. D., Barnes, J. F., Hart, H., Nolan, D. A., & Spowart, K. (1998) · Osteoporosis International · doi:10.1007/s001980050071 · Cited by 25
C to T and/or G to A transitions are responsible for loss of a MspI restriction site at the 5?-end of the human apolipoprotein AI gene
Wang, X. L., Badenhop, R. F., Humphrey, K. E., & Wilcken, D. E. L. (1995) · Human Genetics · doi:10.1007/bf00208984 · Cited by 25
Plasma lipoprotein and apolipoprotein levels in Taipei and Framingham.
Lyu, L. C., Shieh, M.-J., Ordovás, J. M., Lichtenstein, A. H., Wilson, P. W., & Schaefer, E. J. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.10.1429 · Cited by 25
Cholesterol esters selectively delivered in vivo by high-density-lipoprotein subclass LpA-I to rat liver are processed faster into bile acids than are LpA-I/A-II-derived cholesterol esters
Pieters, M. N., Castro, G. R., Schouten, D., Duchateau, P. N., Fruchart, J., & van Berkel, T. J. C. (1993) · Biochemical Journal · doi:10.1042/bj2920819 · Cited by 25
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
German, C. A., & Shapiro, M. D. (2020) · European Cardiology Review · doi:10.15420/ecr.2019.18 · Cited by 24
Update of HDL in atherosclerotic cardiovascular disease
Schoch, L., Alcover, S., Padró, T., Ben‐Aicha, S., Mendieta, G., Badimón, L., & Vilahur, G. (2023) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2023.10.002 · Cited by 25
Influence of food components on lipid metabolism: scenarios and perspective on the control and prevention of dyslipidemias
Frota, K. D. M. G., Matias, A. C. G., & Arêas, J. A. G. (2010) · Food Science and Technology · doi:10.1590/s0101-20612010000500002 · Cited by 25
Low High-Density Lipoprotein Cholesterol and Increased Cardiovascular Disease Risk: An Analysis of Statin Clinical Trials
DEEDWANIA, P. C., Singh, V. N., & Davidson, M. H. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.09.013 · Cited by 24
High-density lipoprotein levels and risk of cardiovascular events
Mureddu, G. F., Brandimarte, F., & Luca, L. D. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834bb3c8 · Cited by 26
Low Levels of High-Density Lipoprotein Cholesterol (Hypoalphalipoproteinemia)
Rosenson, R. S. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410130030004 · Cited by 24
Development of a homogeneous assay for measurement of high-density lipoprotein-subclass cholesterol
Ito, Y., Satoh, N., Ishii, T., Kumakura, J., & Hirano, T. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.09.009 · Cited by 24
Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.
Rabkin, S. W., Huff, M. W., Newman, C., Sim, D. A., & Carruthers, S. G. (1994) · Hypertension · doi:10.1161/01.hyp.24.2.241 · Cited by 24
Lipid profile and Atherogenic Indices in Nigerians Occupationally Exposed to e-waste: A Cardiovascular Risk Assessment Study
Igharo, O. G., Akinfenwa, Y., Isara, A. R., Idomeh, F. A., Nwobi, N. L., Anetor, J. I., & Osibanjo, O. (2020) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2020.15.2.196 · Cited by 24
Relationship of High‐Density Lipoprotein Cholesterol With Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention in Patients With Low‐Density Lipoprotein Cholesterol Below 70 mg/dL
Li, X., Guo, Y., Zhu, C., Xu, R., Qing, P., Wu, N., Jiang, L., Xu, B., Gao, R., & Li, J. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001412 · Cited by 23
HDL3 Exerts a More Powerful Antiperoxidative and Protective Effect against Peroxidative Modification of LDL than HDL2 Does.
SAKUMA, N., Yoshikawa, M., Hibino, T., Ohte, N., Kamiya, T., KUNIMATSU, M., Kimura, G., & Inoue, M. (2002) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.48.278 · Cited by 23
Effects of Atorvastatin on Nuclear Magnetic Resonance-Defined Lipoprotein Subclasses and Inflammatory Markers in Patients with Hypercholesterolemia
Ikewaki, K., Terao, Y., Ozasa, H., Nakada, Y., Tohyama, J., Inoue, Y., & Yoshimura, M. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e563 · Cited by 23
Association of High-Density Lipoprotein Cholesterol With Coronary Heart Disease Risk Across Categories of Low-Density Lipoprotein Cholesterol: The Atherosclerosis Risk in Communities Study
Muntner, P., Lee, F., & Astor, B. C. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181f97e4a · Cited by 25
Dyslipidemia and coronary artery disease
Kuo, P. T. (1994) · Clinical Cardiology · doi:10.1002/clc.4960171003 · Cited by 23
Differential impact of plasma triglycerides on HDL-cholesterol and HDL-apo A-I in a large cohort
Tremblay, A. J., Sniderman, A. D., Gagné, C., Bergeron, J., & Couture, P. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.06.014 · Cited by 23
Prospective Analysis of Lipid Profiles in Persons With a Spinal Cord Injury During and 1 Year After Inpatient Rehabilitation
de Groot, S., Dallmeijer, A. J., Post, M. W. M., Angenot, E. L. D., van den Berg-Emons, R. J. G., & van der Woude, L. H. V. (2008) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2007.11.023 · Cited by 23
The Association of Dietary Cholesterol and Fatty Acids with Dyslipidemia in Chinese Metropolitan Men and Women
Zhu, Z., Wu, F., Lu, Y., Wang, Z., Zang, J., Yu, H., Guo, C., Jia, X., Shen, X., & Ding, G. (2018) · Nutrients · doi:10.3390/nu10080961 · Cited by 23
Comparison of Laboratory Parameters as Risk Factors for the Presence and the Extent of Coronary or Carotid Atherosclerosis: the Significance of Apolipoprotein B to Apolipoprotein AII Ratio
Černe, D., Ledinski, G., Kager, G., Greilberger, J., Wang, X., & Jürgens, G. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.078 · Cited by 23
Treatment strategies for management of serum lipids: Lessons learned from lipid metabolism, recent clinical trials, and experience with the HMG CoA reductase inhibitors
Rubenfire, M., COLETTI, A., & Mosca, L. J. (1998) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(98)80007-8 · Cited by 24
Apolipoproteins and carotid artery atherosclerosis in an elderly multiethnic population: the Northern Manhattan stroke study
Jeng, J., Sacco, R. L., Kargman, D. E., Boden-Albala, B. M., Paik, M. C., Jones, J. S., & Berglund, L. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00246-0 · Cited by 23
High-density lipoprotein reduces epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells
Ko, Y., Häring, R., Stiebler, H., Wieczorek, A. J., Vetter, H., & Sachinidis, A. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90027-r · Cited by 23
Psychosocial Risk Factors and Nonfatal Myocardial Infarction
O’Connor, N. J., Manson, J. E., O’Connor, G. T., & Buring, J. E. (1995) · Circulation · doi:10.1161/01.cir.92.6.1458 · Cited by 23
Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis
van Wijk, J. P. H., Buirma, R. J. A., van Tol, A., Halkes, C. J. M., de Jaegere, P. P. T., Plokker, H. W. M., van der Helm, Y. J. M., & Cabezas, M. C. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.009 · Cited by 23
Inflammation, Aspirin, and the Risk of Cardiovascular Disease
Cahill, M. R., & Perry, I. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370610 · Cited by 23
Addition of estimated cardiorespiratory fitness to the clinical assessment of 10-year coronary heart disease risk in asymptomatic men
Gander, J. C., Sui, X., Hébert, J. R., Lavie, C. J., Hazlett, L. J., Cai, B., & Blair, S. N. (2017) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2017.05.008 · Cited by 23
Association between Apolipoprotein E polymorphism and myocardial infarction risk: A systematic review and meta‐analysis
Wang, Y.-L., Sun, L., Zhang, L., Xu, H., Dong, Z., Wang, L., & Wang, M. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.10.006 · Cited by 22
Macronutrient replacement options for saturated fat
Flock, M. R., Fleming, J. A., & Kris‐Etherton, P. M. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000039 · Cited by 22
Low density lipoprotein cholesterol and whole blood viscosity.
Crowley, J. P., Metzger, J. B., Assaf, A. R., Carleton, R., Merrill, E. W., & VALERI, C. R. (1994) · PubMed · Cited by 22
Opinion of the Scientific Panel on Dietetic products, nutrition and allergies [NDA] related to the presence of trans fatty acids in foods and the effect on human health of the consumption of trans fatty acids
(EFSA), E. F. S. A. (2004) · EFSA Journal · doi:10.2903/j.efsa.2004.81 · Cited by 23

Authors: Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Stampfer, Meir J.
Sacks, Frank M.
Willett, Walter C.
Hennekens, Charles H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08-08
Volume: 325
Issue: 6
Pages: 373-381
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108083250601
OpenAlex: W2337032743
Cited by: 1,163
References: 56
Citations by year: 2026: 6 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 7 · 2021: 12 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 17 · 2016: 24 · 2015: 31 · 2014: 34 · 2013: 33 · 2012: 31
FWCI: 80.75
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL-34595, HL 26490, R01HL034595)
National Cancer Institute (R01CA042182, CA 42182)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: myocardial infarction, HDL cholesterol, HDL2, HDL3, apolipoprotein B-100, apolipoprotein A-I, apolipoprotein A-II, TC/HDL-C ratio, cardiovascular risk prediction, total cholesterol, men, Physicians' Health Study, lipoprotein subfractions, risk factors, coronary heart disease prevention, statin therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Apolipoproteins, Apolipoproteins A, Apolipoproteins B, Cholesterol, Humans, Cholesterol, HDL, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks